Philosophy
Top aides in the Obama administration announced a $2.3 billion settlement on Wednesday with the pharmaceutical giant Pfizer Inc. over the company’s illegal promotion of its now-withdrawn painkiller, Bextra.
It is the largest fine ever levied for fraud in the Medicare and Medicaid programs, and Obama administration officials — criticized by Republicans on Capitol Hill for failing to crack down on fraud in the government’s health programs — sought to highlight the case by having Kathleen Sebelius, secretary of health and human services, make the announcement. The agreement also includes some promotional practices involving other Pfizer drugs — Zyvox, Geodon and Lyrica.
The settlement had been expected. Pfizer, which is acquiring a rival, Wyeth, had reported in January that it had taken a $2.3 billion charge to resolve claims involving Bextra and other drugs. Pfizer shares were down about one percent at mid-day.
Marketing fraud cases against pharmaceutical companies have become almost routine, with almost every major drug maker having been accused of giving kickbacks to doctors or shortchanging the Medicaid program on prices. Prosecutors said that they had become so alarmed by the growing criminality in the industry that they had begun increasing fines into the billions of dollars and would soon start charging doctors individually as well.
Under the agreement with the Justice Department, Pfizer will pay a $1.3 billion criminal penalty related to Bextra and $1 billion in civil fines related to a number of medicines. In addition, a Pfizer subsidiary, Pharmacia and Upjohn Company, will plead guilty to violating the Food, Drug and Cosmetic Act for its promotion of Bextra.
In January, prosecutors announced that they would fine Eli Lilly $1.4 billion for illegal marketing efforts on behalf of Zyprexa, an antipsychotic.
Although the fine amounts began to soar during the Bush administration, top administration officials rarely publicized the cases or appeared during news conferences about them. The Zyprexa case was announced by federal prosecutors in Philadelphia.
Ms. Sebelius’s decision to make the Pfizer announcement in a news conference in Washington suggests that the political environment for the pharmaceutical industry has become more treacherous, despite the industry’s commitment to save the government $80 billion as part of efforts to change the health care system.
Lexapro and Forest Laboratories...bad ethics
- Little Feat, Viagra, And Autonomy
So, I'm driving into work singing along with a '78 Little Feat show and the chorus to Old Folks' Boogie catches me:And you know that you're over the hill When your mind makes a promise that your body can't fill Old folks boogie And...
- Wal-mart In Trouble Again...environmental Problems
Admission of full knowledge of ethical issues... "...Kenneth Woodlin, Wal-Mart’s vice president for compliance, safety and asset protection,...sent more than 2 million pounds of pesticides to a Neosho, Mo., contractor, knowing the material would be...
- Student Loan Program Revamped
Overall this is a good thing [place constraints on dubious vocational schools and banks], but what I question is why it was added to the health care bill. Just understand that if default happens [the student], the government will cover themselves and...
- J. Reece Roth Conviction
J. Reece Roth I am not exactly sure of what to make of this back burner case involving a retired physicist and violation of US law regarding dissemination of sensitive military data. Yesterday a federal jury found J. Reece Roth guilty on 18 counts of...
- Dow Chemical's Greatest Acquisition--ever!
An update to the post regarding a near 50% increase in chemicals by the chemical industry...Dow Chemical will acquire Rohm & Haas to the tune of $15, 300, 000.00. Chemical industry raises prices "Dow Chemical Buying a Rival for $15.3 Billion" by...
Philosophy
Pfizer...spanked for poor ethics
"Pfizer Pays $2.3 Billion to Settle Marketing Case"
by
Gardiner Harris
September 3rd, 2009
The New York Times
by
Gardiner Harris
September 3rd, 2009
The New York Times
Top aides in the Obama administration announced a $2.3 billion settlement on Wednesday with the pharmaceutical giant Pfizer Inc. over the company’s illegal promotion of its now-withdrawn painkiller, Bextra.
It is the largest fine ever levied for fraud in the Medicare and Medicaid programs, and Obama administration officials — criticized by Republicans on Capitol Hill for failing to crack down on fraud in the government’s health programs — sought to highlight the case by having Kathleen Sebelius, secretary of health and human services, make the announcement. The agreement also includes some promotional practices involving other Pfizer drugs — Zyvox, Geodon and Lyrica.
The settlement had been expected. Pfizer, which is acquiring a rival, Wyeth, had reported in January that it had taken a $2.3 billion charge to resolve claims involving Bextra and other drugs. Pfizer shares were down about one percent at mid-day.
Marketing fraud cases against pharmaceutical companies have become almost routine, with almost every major drug maker having been accused of giving kickbacks to doctors or shortchanging the Medicaid program on prices. Prosecutors said that they had become so alarmed by the growing criminality in the industry that they had begun increasing fines into the billions of dollars and would soon start charging doctors individually as well.
Under the agreement with the Justice Department, Pfizer will pay a $1.3 billion criminal penalty related to Bextra and $1 billion in civil fines related to a number of medicines. In addition, a Pfizer subsidiary, Pharmacia and Upjohn Company, will plead guilty to violating the Food, Drug and Cosmetic Act for its promotion of Bextra.
In January, prosecutors announced that they would fine Eli Lilly $1.4 billion for illegal marketing efforts on behalf of Zyprexa, an antipsychotic.
Although the fine amounts began to soar during the Bush administration, top administration officials rarely publicized the cases or appeared during news conferences about them. The Zyprexa case was announced by federal prosecutors in Philadelphia.
Ms. Sebelius’s decision to make the Pfizer announcement in a news conference in Washington suggests that the political environment for the pharmaceutical industry has become more treacherous, despite the industry’s commitment to save the government $80 billion as part of efforts to change the health care system.
Lexapro and Forest Laboratories...bad ethics
- Little Feat, Viagra, And Autonomy
So, I'm driving into work singing along with a '78 Little Feat show and the chorus to Old Folks' Boogie catches me:And you know that you're over the hill When your mind makes a promise that your body can't fill Old folks boogie And...
- Wal-mart In Trouble Again...environmental Problems
Admission of full knowledge of ethical issues... "...Kenneth Woodlin, Wal-Mart’s vice president for compliance, safety and asset protection,...sent more than 2 million pounds of pesticides to a Neosho, Mo., contractor, knowing the material would be...
- Student Loan Program Revamped
Overall this is a good thing [place constraints on dubious vocational schools and banks], but what I question is why it was added to the health care bill. Just understand that if default happens [the student], the government will cover themselves and...
- J. Reece Roth Conviction
J. Reece Roth I am not exactly sure of what to make of this back burner case involving a retired physicist and violation of US law regarding dissemination of sensitive military data. Yesterday a federal jury found J. Reece Roth guilty on 18 counts of...
- Dow Chemical's Greatest Acquisition--ever!
An update to the post regarding a near 50% increase in chemicals by the chemical industry...Dow Chemical will acquire Rohm & Haas to the tune of $15, 300, 000.00. Chemical industry raises prices "Dow Chemical Buying a Rival for $15.3 Billion" by...